P. Archila

发表

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics

R. Rosell, A. Cardona, O. Arrieta, 2021, Translational Oncology.

Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non‐small cell lung cancer (AB‐CLICaP)

R. Rosell, A. Cardona, O. Arrieta, 2020, Thoracic cancer.

Role of Magnetic Resonance in Modifying the Therapeutic Approach in Patients with Diagnosis of Breast Cancer and MRI Findings According to Histological Subtype

P. Archila, C. Heine, Claudia González Encinales, 2017 .

STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP).

Diego F. Chamorro, M. Burotto, R. Rosell, 2022, Lung cancer.

Characteristics and long‐term outcomes of advanced pleural mesothelioma in Latin America (MeSO‐CLICaP)

R. Rosell, A. Cardona, N. Karachaliou, 2019, Thoracic cancer.

Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors

A. Cardona, O. Arrieta, U. Malapelle, 2022, ESMO open.

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non‐small cell lung cancer (NSCLC) compared with chemotherapy (Quijote‐CLICaP)

R. Rosell, A. Cardona, L. Raez, 2019, Thoracic cancer.

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)

R. Rosell, A. Cardona, N. Karachaliou, 2019, Front. Oncol..

Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP)

R. Rosell, A. Cardona, C. Rolfo, 2020, Frontiers in Oncology.

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).

R. Rosell, O. Arrieta, Z. Zatarain-Barrón, 2018, Lung cancer.

EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)

R. Rosell, N. Reguart, A. Cardona, 2018, Targeted Oncology.

Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP)

R. Rosell, N. Reguart, A. Cardona, 2017, Targeted Oncology.

BIM deletion polymorphisms in Hispanic patients with non-small cell lung cancer carriers of EGFR mutations

S. Franco, R. Rosell, N. Reguart, 2016, Oncotarget.

Characteristics and outcomes of thymomas in Latin America: Results from over 10 years of experience (CLICaP‐LATimus)

R. Rosell, A. Cardona, O. Arrieta, 2021, Thoracic cancer.

A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma

C. Balañà, A. Cardona, O. Arrieta, 2019, Clinical and Translational Oncology.

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

R. Rosell, A. Cardona, L. Raez, 2023, Targeted Oncology.

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country

R. Rosell, A. Cardona, O. Arrieta, 2023, Cancer control : journal of the Moffitt Cancer Center.

Outcomes in Latin American NSCLC patients harboring wild-type or activating mutations of EGFR (CLICaP Registry).

R. Rosell, A. Campos-Parra, O. Arrieta, 2012 .

P1.02-050 Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP): Topic: Driver Genes in NSCLC, Resistance, and Other

S. Franco, R. Rosell, N. Reguart, 2017 .

Histological characteristics of chronic gastritis reported in gastric biopsies from children aged 1 to 16 years at the Hospital Infantil de San José from september 2008 to september 2010

P. Archila, L. Tovar, M. Ruíz, 2012 .

Prognostic value of microvascular density and expression of VEGF, EGFR and HIF-1α in patients with locally advanced cervical cancer treated with chemoradiation (ONCOLGroup)§

A. Cardona, L. Reveiz, Á. Muñoz, 2012 .

EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP)

R. Rosell, A. Cardona, C. Rolfo, 2021, JCO precision oncology.

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).

M. Burotto, R. Rosell, A. Cardona, 2022, Clinical lung cancer.

EP16.03-003 Systematic Population-based Identification of NTRK Fusion Genes Among Hispanic Patients with Non-Small Cell Lung Cancer (NSCLC)

L. Raez, O. Arrieta, U. Malapelle, 2022, Journal of Thoracic Oncology.

O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP).

R. Rosell, N. Reguart, A. Cardona, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.